Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome

NCT04355689 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Usher Syndromes

Interventions

DRUG: NPI-001
OTHER: Placebo

Sponsor

Nacuity Pharmaceuticals, Inc.

Collaborators

Foundation Fighting Blindness